Chemotherapy in Locally Advanced, Squamous Cell Head and Neck Cancer: Limitations, Lessons Learned, and Evolving Standards of Care

References

• Urba S G, Forastiere A A. Systemic therapy of head and neck cancer: Most effective agents, areas of promise. Oncology 1989; 3(4)79–88
   PubMedGoogle Scholar
• Dreyfuss A I, Clark J R, Wright J E. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med 1990; 112: 167–172
   PubMed Web of Science ®Google Scholar
• Pfister D G, Bajorin D, Motzer R. Cisplatin. fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1994; 120: 89–95
   PubMed Web of Science ®Google Scholar
• Forastiere A A, Neuberg D, Taylor S G. Phase II evaluation of Taxol in advanced head and neck cancer: An eastern cooperative oncology group trial. Proc Am Soc Clin Oncol 1993; 12: 277, (abstract)
   Google Scholar
• Baselga J, Scott A, Pfister D. Comparative pharmacology in phase I and imaging trials utilizing anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (Mabs) labeled with 1.131 or In-111. Proc Am Soc Clin Oncol 1993; 12: 142, (abstract)
   Google Scholar
• Head and Neck Contracts Program. Adjuvant chemotherapy for advanced head and neck squamous carcinomas. Cancer 1987; 60: 301–311
   PubMed Web of Science ®Google Scholar
• Laramore G E, Scott C B, Al-Sarraf M. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on intergroup study 0034. Int J Radiat Oncol Biol Phys 1992; 23: 705–713
   PubMed Web of Science ®Google Scholar
• The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685–1690
   PubMed Web of Science ®Google Scholar
• Wolf G, Hong W, Fisher S. Larynx preservation with induction chemotherapy (CT) and radiation (XRT) in advanced laryngeal cancer: Final results of the VA laryngeal cancer study group cooperative trial. Proc Am SOC Clin Oncol 1993; 12: 277, (abstract)
   Google Scholar
• Lefebvre J L, Sahmoud T, EORTC Head and Neck Cancer Cooperative Group. Larynx preservation in hypopharynx squamous cell carcinoma: Preliminary results of a randomized study (EORTC 24891). Proc Am Soc Clin Oncol 1994; 13: 283, (abstract)
   Google Scholar
• Pfister D G, Strong E, Harrison L. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol 1991; 9: 850–859
   PubMed Web of Science ®Google Scholar
• Armstrong J, Pftster D, Kraus D. The management of node metastases as part of a larynx preservation approach. Int J Radiat Oncol Biol Phys 1993; 26: 759–765
   PubMed Web of Science ®Google Scholar
• Harrison L B, Pfister D G, Fass D E. A new concomitant chemotherapylradiation therapy program in advanced unresect-able head and neck cancer. Int J Radiat Oncol Biol Phys 1991; 21: 700–708
   Google Scholar
• Vokes E E, Weichselbaum R R. Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990; 8: 911–934
   PubMed Web of Science ®Google Scholar
• Merlano M, Vitale V, Rosso R. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992; 327: 1115–1121
   PubMed Web of Science ®Google Scholar
• Paccagnella A, Orlando A, Marchiori C. Phase 111 trial of initial chemotherapy in stage 111 or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 1994; 86: 265–272
   PubMed Web of Science ®Google Scholar
• Merlano M, Rosso R, Sertoli M R. Sequential versus alternating chemotherapy and radiotherapy in stage III–IV squamous cell carcinoma of the head and neck: A phase 111 study. J Clin Oncol 1988; 6: 627–632
   PubMed Web of Science ®Google Scholar
• Adelstein D J, Sharan V M, Earle A S. Simultaneous versus sequential combined technique therapy for head and neck cancer. Cancer 1990; 65: 1685–1691
   PubMed Web of Science ®Google Scholar
• SECOG. A randomized trial of combined multidmg chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck: An interim report from the SECOG participants. Eur J Surg Oncol 1986; 12: 289–295
   PubMedGoogle Scholar
• Taylor SG, IV, Murthy A K, Vannetzel J-M. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994; 12: 385–395
   PubMed Web of Science ®Google Scholar
• Rosenthal D I, Pistenmaa D A, Glatstein E A. Review of neoadjuvant chemotherapy for head and neck cancer: Partially shrunken tumors may be both leaner and meaner. Int J Radiat Oncol Biol Phys 1994; 28: 315–320
   PubMed Web of Science ®Google Scholar
• Cvitkovic E, Bachouchi M, Armand J-P. Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implications. Hematol/Oncol Clin North Am 1991; 5(4)821–838
   PubMed Web of Science ®Google Scholar
• Peto R, Pike M C, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 1976; 34: 585–612
   PubMed Web of Science ®Google Scholar
• Freiman J A, Chalmers T C, Smith H, Jr. The importance of beta, the type II error and sample size in the design and interpretation of the randomized controlled trial. N Engl J Med 1978; 299: 690–694
   PubMed Web of Science ®Google Scholar
• Jacobs C. Head and neck cancer in 1994 A change in the standard of care. J Natl Cancer Inst 1994; 86: 250–252
   PubMed Web of Science ®Google Scholar